• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素通过下调p53依赖的Bcl-2表达并抑制Mcl-1蛋白稳定性,显著增强双PI3K/Akt和mTOR抑制剂NVP-BEZ235诱导的人肾癌Caki细胞凋亡。

Curcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stability.

作者信息

Seo Bo Ram, Min Kyoung-Jin, Cho Il Je, Kim Sang Chan, Kwon Taeg Kyu

机构信息

Department of Immunology, School of Medicine, Keimyung University, Daegu, South Korea.

College of Oriental Medicine, Daegu Haany University, Gyeongsan, Korea; Medical Research Center for Globalization of Herbal Formulation, Daegu Haany University, Gyeongsan, Korea.

出版信息

PLoS One. 2014 Apr 17;9(4):e95588. doi: 10.1371/journal.pone.0095588. eCollection 2014.

DOI:10.1371/journal.pone.0095588
PMID:24743574
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3990719/
Abstract

The PI3K/Akt and mTOR signaling pathways are important for cell survival and growth, and they are highly activated in cancer cells compared with normal cells. Therefore, these signaling pathways are targets for inducing cancer cell death. The dual PI3K/Akt and mTOR inhibitor NVP-BEZ235 completely inhibited both signaling pathways. However, NVP-BEZ235 had no effect on cell death in human renal carcinoma Caki cells. We tested whether combined treatment with natural compounds and NVP-BEZ235 could induce cell death. Among several chemopreventive agents, curcumin, a natural biologically active compound that is extracted from the rhizomes of Curcuma species, markedly induced apoptosis in NVP-BEZ235-treated cells. Co-treatment with curcumin and NVP-BEZ235 led to the down-regulation of Mcl-1 protein expression but not mRNA expression. Ectopic expression of Mcl-1 completely inhibited curcumin plus NVP-NEZ235-induced apoptosis. Furthermore, the down-regulation of Bcl-2 was involved in curcumin plus NVP-BEZ235-induced apoptosis. Curcumin or NVP-BEZ235 alone did not change Bcl-2 mRNA or protein expression, but co-treatment reduced Bcl-2 mRNA and protein expression. Combined treatment with NVP-BEZ235 and curcumin reduced Bcl-2 expression in wild-type p53 HCT116 human colon carcinoma cells but not p53-null HCT116 cells. Moreover, Bcl-2 expression was completely reversed by treatment with pifithrin-α, a p53-specific inhibitor. Ectopic expression of Bcl-2 also inhibited apoptosis in NVP-BE235 plus curcumin-treated cells. In contrast, NVP-BEZ235 combined with curcumin did not have a synergistic effect on normal human skin fibroblasts and normal human mesangial cells. Taken together, combined treatment with NVP-BEZ235 and curcumin induces apoptosis through p53-dependent Bcl-2 mRNA down-regulation at the transcriptional level and Mcl-1 protein down-regulation at the post-transcriptional level.

摘要

PI3K/Akt和mTOR信号通路对细胞存活和生长至关重要,与正常细胞相比,它们在癌细胞中高度激活。因此,这些信号通路是诱导癌细胞死亡的靶点。双PI3K/Akt和mTOR抑制剂NVP-BEZ235完全抑制了这两条信号通路。然而,NVP-BEZ235对人肾癌Caki细胞的细胞死亡没有影响。我们测试了天然化合物与NVP-BEZ235联合治疗是否能诱导细胞死亡。在几种化学预防剂中,姜黄素是一种从姜黄属植物根茎中提取的天然生物活性化合物,能显著诱导NVP-BEZ235处理细胞的凋亡。姜黄素与NVP-BEZ235联合处理导致Mcl-1蛋白表达下调,但mRNA表达未下调。Mcl-1的异位表达完全抑制了姜黄素加NVP-NEZ235诱导的凋亡。此外,Bcl-2的下调参与了姜黄素加NVP-BEZ235诱导的凋亡。单独使用姜黄素或NVP-BEZ235不会改变Bcl-2 mRNA或蛋白表达,但联合处理会降低Bcl-2 mRNA和蛋白表达。NVP-BEZ235与姜黄素联合处理降低了野生型p53的HCT116人结肠癌细胞中的Bcl-2表达,但对p53缺失的HCT116细胞没有影响。此外,用p53特异性抑制剂pifithrin-α处理可完全逆转Bcl-2表达。Bcl-2的异位表达也抑制了NVP-BE235加姜黄素处理细胞的凋亡。相比之下,NVP-BEZ235与姜黄素联合对正常人皮肤成纤维细胞和正常人系膜细胞没有协同作用。综上所述,NVP-BEZ235与姜黄素联合治疗通过转录水平上p53依赖的Bcl-2 mRNA下调和转录后水平上Mcl-1蛋白下调诱导凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/cc31ef955ee3/pone.0095588.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/fb3ea8cd620b/pone.0095588.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/aee210479d98/pone.0095588.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/3fc2fc2a80c9/pone.0095588.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/6c2fece26a66/pone.0095588.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/dc0d521faa4c/pone.0095588.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/d5dbba7128b6/pone.0095588.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/cc31ef955ee3/pone.0095588.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/fb3ea8cd620b/pone.0095588.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/aee210479d98/pone.0095588.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/3fc2fc2a80c9/pone.0095588.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/6c2fece26a66/pone.0095588.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/dc0d521faa4c/pone.0095588.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/d5dbba7128b6/pone.0095588.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27b6/3990719/cc31ef955ee3/pone.0095588.g007.jpg

相似文献

1
Curcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stability.姜黄素通过下调p53依赖的Bcl-2表达并抑制Mcl-1蛋白稳定性,显著增强双PI3K/Akt和mTOR抑制剂NVP-BEZ235诱导的人肾癌Caki细胞凋亡。
PLoS One. 2014 Apr 17;9(4):e95588. doi: 10.1371/journal.pone.0095588. eCollection 2014.
2
Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma.双重磷酸肌醇 3-激酶/雷帕霉素哺乳动物靶蛋白抑制剂 NVP-BEZ235 具有治疗潜力,并增敏鼻咽癌中的顺铂。
PLoS One. 2013;8(3):e59879. doi: 10.1371/journal.pone.0059879. Epub 2013 Mar 22.
3
NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.NVP-BEZ235,一种新型的双重 PI3K-mTOR 抑制剂,在人神经胶质瘤细胞中显示出抗神经胶质瘤活性,并降低替莫唑胺的化疗耐药性。
Cancer Lett. 2015 Oct 10;367(1):58-68. doi: 10.1016/j.canlet.2015.07.007. Epub 2015 Jul 15.
4
Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.自噬抑制增强PI3K/mTOR抑制剂NVP-BEZ235诱导的乳腺癌细胞增殖抑制和凋亡
Clin Lab. 2015;61(8):1043-51. doi: 10.7754/clin.lab.2015.150144.
5
Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.抑制自噬增强了 PI3K/AKT/mTOR 抑制剂 NVP-BEZ235 在肾癌细胞中诱导的细胞凋亡。
Cell Biochem Funct. 2013 Jul;31(5):427-33. doi: 10.1002/cbf.2917. Epub 2012 Oct 22.
6
PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced.PI3K/mTOR 双重抑制剂 NVP-BEZ235 降低 Mcl-1 表达,并使卵巢癌细胞对 Bcl-xL 靶向策略敏感,前提是诱导 Bim 表达。
Cancer Lett. 2014 Jun 28;348(1-2):38-49. doi: 10.1016/j.canlet.2014.03.001. Epub 2014 Mar 18.
7
Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.PI3K 和 mTORC1/mTORC2 的同时抑制通过下调套细胞淋巴瘤中的 Mcl-1 来克服雷帕霉素诱导的凋亡的耐药性。
Int J Cancer. 2013 Oct 15;133(8):1813-24. doi: 10.1002/ijc.28206. Epub 2013 Jun 15.
8
Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia.新型双重 PI3K-MTORC1/2 抑制剂 NVP-BGT226 在急性白血病中的细胞周期依赖性活性。
Mol Cancer. 2013 May 24;12:46. doi: 10.1186/1476-4598-12-46.
9
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer.双重PI3K/mTOR抑制剂NVP-BEZ235与泛组蛋白去乙酰化酶抑制剂联合治疗对人胰腺癌具有更高疗效。
Oncotarget. 2012 Nov;3(11):1416-27. doi: 10.18632/oncotarget.724.
10
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.双重PI3K和mTOR抑制剂NVP-BEZ235联合甲磺酸伊马替尼对慢性粒细胞白血病细胞系的疗效。
Drug Des Devel Ther. 2017 Apr 3;11:1115-1126. doi: 10.2147/DDDT.S132092. eCollection 2017.

引用本文的文献

1
Anti-tumor Effects of Curcumin and ABT-737 in Combination Therapy for Glioblastoma in Vivo.姜黄素与ABT-737联合治疗胶质母细胞瘤的体内抗肿瘤作用
Int J Mol Cell Med. 2025;14(1):552-566. doi: 10.22088/IJMCM.BUMS.14.1.552.
2
All-trans retinoic acid enhances anti-proliferative effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in triple negative breast cancer.全反式维甲酸增强双PI3K和mTOR抑制剂NVP-BEZ235在三阴性乳腺癌中的抗增殖作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 5. doi: 10.1007/s00210-025-03981-8.
3
Targeting mTOR with curcumin: therapeutic implications for complex diseases.

本文引用的文献

1
Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma.克服肾细胞癌对当前mTOR抑制剂耐药性的新策略。
Biochim Biophys Acta. 2014 Apr;1845(2):221-31. doi: 10.1016/j.bbcan.2014.01.007. Epub 2014 Jan 27.
2
The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes.微粉化粉末和液体胶束中的姜黄素在健康人体中的口服生物利用度显著增加,且在性别之间存在差异。
Mol Nutr Food Res. 2014 Mar;58(3):516-27. doi: 10.1002/mnfr.201300724. Epub 2014 Jan 9.
3
Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil.
用姜黄素靶向雷帕霉素靶蛋白:对复杂疾病的治疗意义。
Inflammopharmacology. 2025 Apr;33(4):1583-1616. doi: 10.1007/s10787-025-01643-y. Epub 2025 Feb 16.
4
Anticancer Drug Discovery from Natural Compounds Targeting PI3K/AKT/mTOR Signaling Pathway.基于靶向PI3K/AKT/mTOR信号通路的天然化合物的抗癌药物发现
Curr Med Chem. 2024 Oct 10. doi: 10.2174/0109298673325229240928040758.
5
Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy.用于癌症治疗的草药疗法:植物治疗功效综述
Biologics. 2024 Sep 10;18:229-255. doi: 10.2147/BTT.S484068. eCollection 2024.
6
SP2509, a specific antagonist of LSD1, exhibits antiviral properties against Porcine epidemic diarrhea virus.SP2509,一种 LSD1 的特异性拮抗剂,表现出抗猪流行性腹泻病毒的抗病毒特性。
BMC Vet Res. 2024 May 10;20(1):187. doi: 10.1186/s12917-024-04052-5.
7
Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment.通过智能温敏型 PLGA 载体传递活性草药成分调节 P53 肿瘤抑制基因和 Mcl-2 癌基因表达,以改善骨肉瘤治疗。
Med Oncol. 2024 Jan 30;41(3):68. doi: 10.1007/s12032-023-02291-4.
8
Synergistic anti-proliferative and apoptotic effect of NVP-BEZ235 and curcumin on human SH-SY5Y neuroblastoma cells.NVP-BEZ235与姜黄素对人SH-SY5Y神经母细胞瘤细胞的协同抗增殖和凋亡作用。
Med Oncol. 2023 Dec 10;41(1):11. doi: 10.1007/s12032-023-02239-8.
9
Baicalein as Promising Anticancer Agent: A Comprehensive Analysis on Molecular Mechanisms and Therapeutic Perspectives.黄芩素作为有前景的抗癌药物:分子机制与治疗前景的综合分析
Cancers (Basel). 2023 Apr 3;15(7):2128. doi: 10.3390/cancers15072128.
10
Salt-Tolerant Plants, Halophytes, as Renewable Natural Resources for Cancer Prevention and Treatment: Roles of Phenolics and Flavonoids in Immunomodulation and Suppression of Oxidative Stress towards Cancer Management.耐盐植物(盐生植物)作为预防和治疗癌症的可再生自然资源:酚类和类黄酮在免疫调节和抑制氧化应激方面对癌症管理的作用。
Int J Mol Sci. 2023 Mar 8;24(6):5171. doi: 10.3390/ijms24065171.
姜黄素介导的乳腺癌细胞对 5-氟尿嘧啶化疗增敏作用的信号转导调控的机制评价。
Cell Death Dis. 2013 Feb 21;4(2):e505. doi: 10.1038/cddis.2013.26.
4
Efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 in a preclinical model of adrenocortical carcinoma.新型双重 PI3-激酶/mTOR 抑制剂 NVP-BEZ235 在肾上腺皮质癌的临床前模型中的疗效。
Mol Cell Endocrinol. 2012 Nov 25;364(1-2):101-4. doi: 10.1016/j.mce.2012.08.014. Epub 2012 Aug 31.
5
Curcumin--from molecule to biological function.姜黄素——从分子到生物学功能。
Angew Chem Int Ed Engl. 2012 May 29;51(22):5308-32. doi: 10.1002/anie.201107724. Epub 2012 May 4.
6
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer.肾细胞癌中磷脂酰肌醇-3 激酶(PI3K)和雷帕霉素靶蛋白(mTOR)的特征和靶向治疗。
J Transl Med. 2011 Aug 11;9:133. doi: 10.1186/1479-5876-9-133.
7
Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib.用双重 PI3K/mTOR 抑制剂 NVP-BEZ235 联合索拉非尼靶向肾细胞癌。
Mol Cancer. 2011 Jul 26;10:90. doi: 10.1186/1476-4598-10-90.
8
Augmentation of NVP-BEZ235's anticancer activity against human lung cancer cells by blockage of autophagy.通过阻断自噬来增强 NVP-BEZ235 对人肺癌细胞的抗癌活性。
Cancer Biol Ther. 2011 Sep 15;12(6):549-55. doi: 10.4161/cbt.12.6.16397.
9
Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in hepatocellular carcinoma cell lines.NVP-BEZ235,一种双重 PI3K/mTOR 抑制剂,对肝癌细胞系的生长抑制作用。
Oncol Rep. 2011 Nov;26(5):1273-9. doi: 10.3892/or.2011.1370. Epub 2011 Jul 1.
10
mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.mTORC1 和 mTORC2 通过 RhoA 和 Rac1 信号通路调节结直肠癌的 EMT、迁移和转移。
Cancer Res. 2011 May 1;71(9):3246-56. doi: 10.1158/0008-5472.CAN-10-4058. Epub 2011 Mar 23.